These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. MicroPET imaging of brain tumor angiogenesis with 18F-labeled PEGylated RGD peptide. Chen X; Park R; Hou Y; Khankaldyyan V; Gonzales-Gomez I; Tohme M; Bading JR; Laug WE; Conti PS Eur J Nucl Med Mol Imaging; 2004 Aug; 31(8):1081-9. PubMed ID: 15118844 [TBL] [Abstract][Full Text] [Related]
8. N-Succinimidyl 4-[(18)F]-fluoromethylbenzoate-labeled dimeric RGD peptide for imaging tumor integrin expression. Li W; Lang L; Niu G; Guo N; Ma Y; Kiesewetter DO; Shen B; Chen X Amino Acids; 2012 Sep; 43(3):1349-57. PubMed ID: 22209865 [TBL] [Abstract][Full Text] [Related]
9. 18F-labeled bombesin analogs for targeting GRP receptor-expressing prostate cancer. Zhang X; Cai W; Cao F; Schreibmann E; Wu Y; Wu JC; Xing L; Chen X J Nucl Med; 2006 Mar; 47(3):492-501. PubMed ID: 16513619 [TBL] [Abstract][Full Text] [Related]
10. 18F-labeled BBN-RGD heterodimer for prostate cancer imaging. Li ZB; Wu Z; Chen K; Ryu EK; Chen X J Nucl Med; 2008 Mar; 49(3):453-61. PubMed ID: 18287274 [TBL] [Abstract][Full Text] [Related]
11. A thiol-reactive 18F-labeling agent, N-[2-(4-18F-fluorobenzamido)ethyl]maleimide, and synthesis of RGD peptide-based tracer for PET imaging of alpha v beta 3 integrin expression. Cai W; Zhang X; Wu Y; Chen X J Nucl Med; 2006 Jul; 47(7):1172-80. PubMed ID: 16818952 [TBL] [Abstract][Full Text] [Related]
13. Micro-PET imaging of alphavbeta3-integrin expression with 18F-labeled dimeric RGD peptide. Chen X; Tohme M; Park R; Hou Y; Bading JR; Conti PS Mol Imaging; 2004 Apr; 3(2):96-104. PubMed ID: 15296674 [TBL] [Abstract][Full Text] [Related]
14. Biodistribution and pharmacokinetics of the alphavbeta3-selective tracer 18F-galacto-RGD in cancer patients. Beer AJ; Haubner R; Goebel M; Luderschmidt S; Spilker ME; Wester HJ; Weber WA; Schwaiger M J Nucl Med; 2005 Aug; 46(8):1333-41. PubMed ID: 16085591 [TBL] [Abstract][Full Text] [Related]
15. (64)Cu-labeled tetrameric and octameric RGD peptides for small-animal PET of tumor alpha(v)beta(3) integrin expression. Li ZB; Cai W; Cao Q; Chen K; Wu Z; He L; Chen X J Nucl Med; 2007 Jul; 48(7):1162-71. PubMed ID: 17574975 [TBL] [Abstract][Full Text] [Related]
16. Click chemistry for (18)F-labeling of RGD peptides and microPET imaging of tumor integrin alphavbeta3 expression. Li ZB; Wu Z; Chen K; Chin FT; Chen X Bioconjug Chem; 2007; 18(6):1987-94. PubMed ID: 18030991 [TBL] [Abstract][Full Text] [Related]
17. 18F-labeled galacto and PEGylated RGD dimers for PET imaging of αvβ3 integrin expression. Liu S; Liu Z; Chen K; Yan Y; Watzlowik P; Wester HJ; Chin FT; Chen X Mol Imaging Biol; 2010 Oct; 12(5):530-8. PubMed ID: 19949981 [TBL] [Abstract][Full Text] [Related]
18. Noninvasive imaging of tumor integrin expression using (18)F-labeled RGD dimer peptide with PEG (4) linkers. Liu Z; Liu S; Wang F; Liu S; Chen X Eur J Nucl Med Mol Imaging; 2009 Aug; 36(8):1296-307. PubMed ID: 19296102 [TBL] [Abstract][Full Text] [Related]
19. (64)Cu labeled AmBaSar-RGD2 for micro-PET imaging of integrin αvβ3 expression. Cai H; Li Z; Huang CW; Park R; Conti PS Curr Radiopharm; 2011 Jan; 4(1):68-74. PubMed ID: 22191616 [TBL] [Abstract][Full Text] [Related]
20. Quantitative analysis and comparison study of [18F]AlF-NOTA-PRGD2, [18F]FPPRGD2 and [68Ga]Ga-NOTA-PRGD2 using a reference tissue model. Guo N; Lang L; Li W; Kiesewetter DO; Gao H; Niu G; Xie Q; Chen X PLoS One; 2012; 7(5):e37506. PubMed ID: 22624041 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]